gene editing Archives - Page 2 of 3

Shape Shifting NY Times Headline on Gene Drive Becomes More Positive

June 13, 2016 / Professor Paul Knoepfler, Ph.D.

Harmon-Gene-Drive-article-headline-e1465586439647

After the NY Times published an article on June 8th on the exciting, controversial technology called gene drive that can alter the genome of an entire species, strangely the article’s headline changed at least twice. The article was focused on a National Academy panel studying this technology. The headline gradually evolved to become much more positive in tone. You […]

Shape Shifting NY Times Headline on Gene Drive Becomes More Positive Read More »

NgAgo a-go-go: main bullet points on upstart CRISPR challenger

May 25, 2016 / Professor Paul Knoepfler, Ph.D.

The gene editing technology CRISPR has been arguably the top story in the biomedical world in the last two years, but going forward there is a CRISPR challenger in upstart gene editing technology NgAgo. For more background on NgAgo and the key first published paper on its genetic modification characteristics see my post here. In the comments on that

NgAgo a-go-go: main bullet points on upstart CRISPR challenger Read More »

Will new gene editing tech NgAgo challenge CRISPR?

May 15, 2016 / Professor Paul Knoepfler, Ph.D. / 17 Comments

2020 Update: early NgAgo reports have been mostly discredited and there is doubt on its function as a gene-editing method. What could be better than CRISPR for gene editing? A new genetic modification technology called NgAgo has some researchers really excited. How does it compare to CRISPR? I’ll admit it that as a scientist who works on

Will new gene editing tech NgAgo challenge CRISPR? Read More »

In Depth Report from April 29th Paris Human Gene Editing Meeting

May 11, 2016 / Professor Paul Knoepfler, Ph.D.

Editor’s note. Caroline Simons attended both the April 28th (see her report on that here) and 29th Paris meetings on human gene editing/genetic modification. Today, we have her in depth report on the April 29th meeting. I have posted her piece in full with only minor edits. If you are in a rush you can

In Depth Report from April 29th Paris Human Gene Editing Meeting Read More »

Scoop on this week’s Paris human gene editing meetings

April 26, 2016 / Professor Paul Knoepfler, Ph.D.

This week there will be two meetings in Paris as part of the ongoing international dialogue on human genetic modification/human gene editing, CRISPR, and figuring out a wise path forward. A one-day workshop will be held on April 28th “jointly organised by the Federation of European Academies of Medicine (FEAM), the UK Academy of Medical

Scoop on this week’s Paris human gene editing meetings Read More »

Follow up Gene Editing Meeting to be Held in Paris in April on Human CRISPR

March 14, 2016 / Professor Paul Knoepfler, Ph.D.

Back in December, the US National Academies held a first of its kind meeting on human gene editing. Keeping the dialogue going, there is a follow up meeting planned for April 29 in Paris, France. The Paris meeting is described this way: “Upcoming Public Meeting in Paris The consensus committee will host a public meeting

Follow up Gene Editing Meeting to be Held in Paris in April on Human CRISPR Read More »

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit

December 4, 2015 / Professor Paul Knoepfler, Ph.D. / 7 Comments

I just got back from a historic summit on human genetic modification in Washington, D.C. New genetic modification technology, termed CRISPR-Cas9, has both made genetic modification a relatively simple matter for scientists and human genetic modification much more likely in the near future. Heritable human genetic modification could prevent some rare genetic diseases so there

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit Read More »

Live Blogging #GeneEditSummit Day 1 Post #4: Societal Implications of human gene editing

December 1, 2015 / Professor Paul Knoepfler, Ph.D. / 4 Comments

This is post #4 of my live blogging of the #GeneEditSummit today. It is focused on societal implications so I’m really looking forward to it. You can read posts 1-3, here, here, and here summarizing the talks and key points from the meeting so far. Annelien L. Bredenoord, University Medical Center Utrecht, chaired the session. John Harris,

Live Blogging #GeneEditSummit Day 1 Post #4: Societal Implications of human gene editing Read More »

Live Blogging NAS Human Gene Editing Summit: #GeneEditSummit

November 28, 2015 / Professor Paul Knoepfler, Ph.D.

The National Academy of Sciences (NAS) summit on Human Gene Editing will begin in a few days on December 1 in Washington, D.C. This summit is in part the extension of discussions that started at a more informal meeting on CRISPR earlier this year in Napa organized by Jennifer Doudna and colleagues. The NAS meeting

Live Blogging NAS Human Gene Editing Summit: #GeneEditSummit Read More »

FDA approves 1st GM animal (fast-growing salmon) to eat

November 19, 2015 / Professor Paul Knoepfler, Ph.D. / 14 Comments

After a seemingly endless period of review, the FDA has approved the genetically modified (GM) AquaBounty salmon for sale and consumption. Update: You might find my interview with George Church on CRISPR and gene modification interesting. I don’t see any particular reason to think that this GM fish as a food would pose any significant

FDA approves 1st GM animal (fast-growing salmon) to eat Read More »

gene editing

Subscribe to Our Newsletter